In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...

Morning! Today, we preview a contentious generic drug dispute that may end up at the Supreme Court, discuss how the FDA’s new ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — A sperm donor who unknowingly carried a gene variant that can ...

More than 100,000 people are enrolled in M.D. programs for the 2025-2026 academic year, according to data released yesterday by the Association of American Medical Colleges. It’s the first time total ...

In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...

ASH's 2025 meeting ended with strong multiple myeloma data from J&J, a new treatment for a rare disorder, and strains on a ...

In today's D.C. Diagnosis newsletter, the Biosecure Act advances, but extra ACA subsidies are still up in the air.

Happy 40th birthday — now come in for your health checkup. That's one way Slovenia is lowering rates of chronic disease.

Care for patients with dementia has changed radically since Jason Karlawish started working in the field in the late ’90s, he says on STAT’s “First Opinion Podcast.” ...

Kuppalli is an infectious diseases physician in Dallas. I have spent my career caring for people facing some of the world’s most dangerous infectious diseases — Ebola, mpox, Covid-19. I have worked in ...

The chaos created by the freezing and termination of billions of dollars of research grants has left trans academics ...

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...